Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

Market Cap	3.13B -21.7%
Revenue (ttm)	373.49M +26.6%
Net Income	109.68M +24.5%
EPS	1.64 +23.4%
Shares Out	66.70M
PE Ratio	28.62
Forward PE	n/a
Dividend	0.70 (1.48%)
Ex-Dividend Date	Jun 1, 2026

Volume	689,500
Open	47.42
Previous Close	47.31
Day's Range	46.08 - 47.78
52-Week Range	44.88 - 92.50
Beta	0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 17, 2026

About SHE:301033

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 447
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301033

Financial Performance

In 2025, SHE:301033's revenue was 368.83 million, an increase of 32.46% compared to the previous year's 278.44 million. Earnings were 113.13 million, an increase of 43.47%.